112 related articles for article (PubMed ID: 20154488)
1. [A case of complete response treated by S-1 with concurrent radiotherapy for a gefitinib-resistant non-small cell lung cancer patient].
Fujimoto H; Oyama T; Suito T; Hashimoto K; Kameyama Y; Yasuda H; Ishizuka H
Gan To Kagaku Ryoho; 2010 Feb; 37(2):295-8. PubMed ID: 20154488
[TBL] [Abstract][Full Text] [Related]
2. [Two cases of long-term response treated by S-1 with concurrent radiotherapy followed by S-1 treatment for non-small cell lung cancer patients].
Fujimoto H; Suito T; Oyama T; Kameyama Y; Nakayama S
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1539-41. PubMed ID: 23064067
[TBL] [Abstract][Full Text] [Related]
3. [A case of non-small cell lung cancer with EGFR mutation responding to S-1 after a therapy with gefitinib].
Kawano O; Yano M; Sasaki H; Yukiue H; Okuda K; Fujii Y
Gan To Kagaku Ryoho; 2009 Apr; 36(4):675-7. PubMed ID: 19381047
[TBL] [Abstract][Full Text] [Related]
4. [Two cases of recurrent non-small cell lung cancer successfully treated with S-1 as fifth-line chemotherapy].
Takakuwa O; Oguri T; Sato S; Nakao M; Ohta C; Iwashima Y; Miyazaki M; Maeno K; Kutsuna T; Nakamura A; Ueda R
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1721-4. PubMed ID: 19838034
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer.
Stinchcombe TE; Morris DE; Lee CB; Moore DT; Hayes DN; Halle JS; Rivera MP; Rosenman JG; Socinski MA
J Thorac Oncol; 2008 Mar; 3(3):250-7. PubMed ID: 18317067
[TBL] [Abstract][Full Text] [Related]
6. [Two cases with recurrent non-small cell lung cancer successfully treated with cisplatin and S-1].
Hirose T; Hosaka T; Nakashima M; Sugiyama T; Ishida H; Yamaoka T; Okuda K; Adachi M
Gan To Kagaku Ryoho; 2008 Feb; 35(2):327-30. PubMed ID: 18281776
[TBL] [Abstract][Full Text] [Related]
7. [A case of long-term survival after resection of aortic arch for locally advanced non-small cell lung cancer with induction chemotherapy].
Higuchi M; Suzuki H; Shio Y; Satoh Y; Kitamura M; Gotoh M
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1349-52. PubMed ID: 21829079
[TBL] [Abstract][Full Text] [Related]
8. [Pathological complete response in advanced gastric carcinoma by S-1/CDDP combination chemotherapy].
Toriumi F; Ei S; Takahashi H; Okada R; Masai K; Mito M; Ishimaru N; Mizuno K; Handa K; Yamanashi T; Koshida Y; Akamatsu H; Motegi K; Tajima T; Mukai K; Shimoyama Y
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1183-6. PubMed ID: 21772108
[TBL] [Abstract][Full Text] [Related]
9. [An Elderly Patient with Non-Small Cell Lung Cancer Who Responded to Salvage S-1 Monotherapy after Gefitinib Therapy].
Mouri A; Hamamoto Y; Kameyama N; Ibe T; Takeoka S; Honma C; Fukusumi M; Kamimura M
Gan To Kagaku Ryoho; 2015 Sep; 42(9):1091-3. PubMed ID: 26469166
[TBL] [Abstract][Full Text] [Related]
10. [A case of recurrent non-small cell lung cancer successfully treated with multiple modality therapies including S-1 monotherapy as fifth-line chemotherapy hospital)].
Yokosuka T; Kobayashi T; Enomoto T; Takeda A
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1201-3. PubMed ID: 24047779
[TBL] [Abstract][Full Text] [Related]
11. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
[TBL] [Abstract][Full Text] [Related]
12. A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small cell lung cancer.
Center B; Petty WJ; Ayala D; Hinson WH; Lovato J; Capellari J; Oaks T; Miller AA; Blackstock AW
J Thorac Oncol; 2010 Jan; 5(1):69-74. PubMed ID: 20035186
[TBL] [Abstract][Full Text] [Related]
13. [Complete response by S-1 with multiple pulmonary metastases 4 years after lung resection-a case report].
Sugiura Y; Takeuchi K; Kakizaki T; Kaseda S
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2611-4. PubMed ID: 20009464
[TBL] [Abstract][Full Text] [Related]
14. [A case of preoperative concurrent chemoradiotherapy and curative resection for locally advanced non-small-cell lung cancer].
Teruya T; Ikeda J; Yamaguchi M; Ushijima C; Asoh H; Fukuyama Y; Ichinose Y
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1791-4. PubMed ID: 12402431
[TBL] [Abstract][Full Text] [Related]
15. [A case of advanced gastric cancer with distant lymph node metastases in cervical, supraclavicular and superior mediastinum successfully treated with S-1/Cisplatin (CDDP)/Lentinan combination chemotherapy].
Kinoshita K; Kondo K; Watanabe K
Gan To Kagaku Ryoho; 2010 Apr; 37(4):707-10. PubMed ID: 20414031
[TBL] [Abstract][Full Text] [Related]
16. [A case of cervical lymph node recurrence of advanced gastric cancer responding to combination therapy of S-1, CDDP and docetaxel].
Sugishita H; Ishida N; Yoshida M; Sato K; Doi T; Horiuchi A; Watanabe Y
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1385-8. PubMed ID: 20647733
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
18. Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease).
Phernambucq EC; Biesma B; Smit EF; Paul MA; vd Tol A; Schramel FM; Bolhuis RJ; Postmus PE
Br J Cancer; 2006 Aug; 95(4):470-4. PubMed ID: 16909132
[TBL] [Abstract][Full Text] [Related]
19. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
20. [A case of submandibular gland cancer in elderly patients showed significant effect by S-1 and intravenous docetaxel chemotherapy concurrent with radiotherapy].
Kubota K; Sato H; Sakaki H; Nakagawa H; Kon T; Narita N; Kobayashi W; Kimura H
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1937-40. PubMed ID: 20948259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
